» Articles » PMID: 8828879

Opiate-dependent Patients Receiving Methadone. How Physicians Should Manage Therapy

Overview
Date 1996 Sep 1
PMID 8828879
Authors
Affiliations
Soon will be listed here.
Abstract

Methadone treatment can reduce illicit drug use, needle sharing, and the social costs and health risks of heroin addiction. It is superior to no treatment, detoxification, or treatment programs lasting less than 3 months. For most patients, the optimal methadone dose is 50 to 120 mg daily. Supervised, random urine drug specimens should be collected at least twice weekly. Long-term counseling is essential and should include information on the risks of needle sharing and on screening for HIV and hepatitis B and C.

References
1.
Bell J, SERES V, Bowron P, Lewis J, Batey R . The use of serum methadone levels in patients receiving methadone maintenance. Clin Pharmacol Ther. 1988; 43(6):623-9. DOI: 10.1038/clpt.1988.86. View

2.
Kaltenbach K, Finnegan L . Perinatal and developmental outcome of infants exposed to methadone in-utero. Neurotoxicol Teratol. 1987; 9(4):311-3. DOI: 10.1016/0892-0362(87)90021-3. View

3.
Hans S . Developmental consequences of prenatal exposure to methadone. Ann N Y Acad Sci. 1989; 562:195-207. DOI: 10.1111/j.1749-6632.1989.tb21018.x. View

4.
Cooper J . Methadone treatment and acquired immunodeficiency syndrome. JAMA. 1989; 262(12):1664-8. View

5.
Davis G, BALART L, Schiff E, Lindsay K, Bodenheimer Jr H, Perrillo R . Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med. 1989; 321(22):1501-6. DOI: 10.1056/NEJM198911303212203. View